Exactech Vantage Total Ankle System
510(k) K152217
Exactech Vantage Total Ankle System is a Class II device made by Exactech, Inc., cleared under FDA 510(k) K152217 on 10 Mar 2016, active as of 22 Oct 2026. 5 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
3 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK152217 | Date10 Mar 2016 | StatusActive |
Official records
- FDA 510(k) database K152217
Recalls
-
- Ongoing Z-0587-2024
Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.
-
- Ongoing Z-0024-2022
Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.
-
- Ongoing Z-2926-2020
The Vantage Total Ankle Tibial Insert, Fixed Bearing, Size 4, Right 10mm, were found to have a labeling error. Exactech is recalling the Vantage Total Ankle Tibial Insert, Fixed Bearing, Size 4, Right 10mm because they were found to have a labeling error. The upper right corner of the label incorrectly identifies the implant size as 3 when the implant size is 4.
-
- Terminated Z-2966-2018
Exactech is recalling the Tibial Alignment Guide because the Global Trade Item Number (GTIN) on the device is incorrect. The GTIN on the device reads 10885862525629, when it should read 10885862525628.
-
- Terminated Z-0200-2018
- Terminated Z-0201-2018
Possible inner labeling and packaged device not matching the outer label on the box.
Timeline
- Cleared FDA 510(k) K152217
- Recall initiated FDA recalls Z-0200-2018
- Recall initiated FDA recalls Z-0201-2018
- Recall initiated FDA recalls Z-2966-2018
- Recall initiated FDA recalls Z-2926-2020
- Recall initiated FDA recalls Z-0024-2022
- Recall initiated FDA recalls Z-0587-2024
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- HSN
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3110
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent